Category: Money tips Release Date: 2006-11-09
Today, tape heavy volume fell, the lowest intraday exploration to 1147 points, again swept the market panic.
Wang wealth has been looking silly, and he did not believe so comes to an end of the tape. Extremely depressed, it is also an access to a smoker. Apparently has not made his mind.
Zhang Ting also felt intermittent cold hit, though not yet to late autumn, they are wind and rain, cold pressing.
She noted that out of the window the garden pavilion, there is a group of egrets hide the wind and rain, are habitats in the pavilion, the leisurely feeding and walking, without let-loss fiber.
Ting mind a move, she would like to let's people in the stock market, although Shenbuyouyi, but why not learn the group of egrets do hide the wind and rain, so can at least live a little longer.
Professor Niu nodded in favor, although he is expected to be adjusted before the holiday broader market turmoil, but the short side so crazy, so that the market reflects the obvious has gone too far.
At such times, to avoid the risk is more important than the opportunity.
He found that short intraday strength mainly from three aspects:
First, this large proportion of stocks to increase prices, as the proportion of shareholding dispersion on the price of low-Minsheng Bank resume trading has been a downward spiral, led banking stocks lower, which is we need to avoid the hardest hit.
Second, containing H shares in the petrochemical heavyweight inaction, the formation of a larger negative impact on the index, these heavyweight in the main signs of apparent escape.
Thirdly, the recent explosion of non-performance of support or support for growth stocks, hot money Xianshibumiao, pulled out.
From the above three aspects of analysis, currently on the market, only 10-20% of the stocks are safe, or relatively strong defensive play.
That is part of the performance with growth, and the pre-has seriously oversold stocks.
In particular, pharmaceutical stocks have become Ruoshi plate in the strong, stocks Tin Lok view, Xinhua Pharmaceutical (000,756 market, information, advice, more) only low-cost medical topics that we share a good place to hide the wind and rain.
Xinhua Pharmaceutical (000,756 market, information, advice, more) is Asia's largest antipyretic and analgesic drugs production and export base, and an internal anti-infective classes, cardiovascular and cerebrovascular categories, central nervous system type and other types of drugs important to the production enterprise.
After several years of rapid development, has become a dominant area of our raw material medicine, and its products analgin, caffeine, aminopyrine, aspirin, are located in the domestic market share in the first place, a monopoly is extremely prominent.
In addition, the company and the United States Perrigo International, Inc. formed a joint venture in Zibo Xinhua - Perrigo Pharmaceutical Co., Ltd. a major breakthrough in the successful development of a special particle size of the ibuprofen products, future market prospects.
Of particular concern is that in the strong support of the relevant departments under the Shanghai Pharmaceutical Group and Shandong Xinhua Pharmaceutical Group of the reorganization of being anti-established goals step by step, close, re-docking the two businesses have been progressive to a new stage. The Xinhua Pharmaceutical will also gain from the strong-strong alliance huge benefits.
I have found, Xinhua Pharmaceutical recent formation of a typical low V-reversal patterns, the stock has been successfully broken up a number of key moving average, do more kinetic energy is constantly gathering, soon pulled up. (Your opponent on the price of the stock held by the program satisfied? You think a reasonable price should be the right number? - Soon send short �letter to vote! Write "JF01 or JF02", 01 on behalf of "satisfactory", 02 stands for "unsatisfactory." Mobile users sent to 2.9116 million + stock symbol (eg, 2911600600104), China Unicom users send to 9.9016 million + stock code)
Professor Niu, Thursday the Shenzhen and Shanghai stock index continued to show the sharp decline in the trend, but the late emergence of some recovery, indicating that the sharp decline in a row, the market has been faced with a rebound opportunity. Operation, focusing on growth stocks oversold low-cost medicines.